Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Results 1 - 20 of 188 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar clangmead (34.60) Submitted: 12/23/2014 9:05:18 AM : Outperform Start Price: $71.67 LLY Score: -1.92

pattern 4; sell by jan 5, then short

Recs

0
Member Avatar 1badbeerad (32.99) Submitted: 12/16/2014 6:11:19 PM : Outperform Start Price: $69.22 LLY Score: +1.42

Nice dividend company.

Recs

0
Member Avatar afewgoodstocks11 (25.53) Submitted: 2/18/2014 6:56:52 PM : Outperform Start Price: $35.62 LLY Score: +35.55

Div. (Yield) $1.96 (3.6%)
Current Yield . . . . . 5.37%

Recs

0
Member Avatar theActuary (53.16) Submitted: 1/14/2014 8:00:24 AM : Outperform Start Price: $50.47 LLY Score: +25.11

LLY woot

Recs

0
Member Avatar knockripper (37.36) Submitted: 11/15/2013 9:20:56 AM : Outperform Start Price: $49.24 LLY Score: +26.86

Great Company, health care reform.

Recs

0
Member Avatar jmpeavler (< 20) Submitted: 8/12/2013 5:54:29 PM : Underperform Start Price: $53.68 LLY Score: -8.10

most of their drugs have gone genetic. A couple of new ones (diabetes and dementia) don't seem to be making much progress with testing. good dependable dividends.

Recs

1
Member Avatar Teacherman333 (84.02) Submitted: 6/1/2013 1:14:36 PM : Outperform Start Price: $51.54 LLY Score: +8.85

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 31.07%
Trailing PE 12.78
PB 3.92
Div yield 3.60%

Recs

1
Member Avatar 6sigmaford (< 20) Submitted: 11/15/2012 12:02:53 PM : Outperform Start Price: $42.68 LLY Score: +10.98

Diabetes will be around a long time and so will Lilly.

Recs

0

Recs

0
Member Avatar GVA1 (< 20) Submitted: 10/14/2012 9:58:32 AM : Outperform Start Price: $47.02 LLY Score: +4.16

Surprising success in Alzheimer's portfolio

Recs

0
Member Avatar TMFBiologyFool (96.79) Submitted: 10/12/2012 12:25:24 PM : Underperform Start Price: $46.65 LLY Score: -4.90

Over exuberance for Alzheimer's program.

Recs

0
Member Avatar FoolWithFive (99.57) Submitted: 7/25/2012 12:04:25 PM : Outperform Start Price: $39.66 LLY Score: +21.69

They are the heart and soul of indianapolis. This company does great things for the state of Indiana and health care!

Recs

1
Member Avatar einzling44 (23.09) Submitted: 5/15/2012 4:04:46 AM : Underperform Start Price: $37.32 LLY Score: -33.07

cap spending ahead

Recs

0
Member Avatar slih (< 20) Submitted: 1/26/2012 12:58:31 AM : Outperform Start Price: $35.58 LLY Score: +41.29

veternary products; retained corporate brainpower

Recs

0
Member Avatar fooluser17 (< 20) Submitted: 1/19/2012 2:04:19 PM : Outperform Start Price: $35.81 LLY Score: +38.05

Dividend rockstar, most numbers are good. Probably make this one 1%.

Recs

0
Member Avatar jesseangels (< 20) Submitted: 1/13/2012 7:41:59 PM : Outperform Start Price: $35.80 LLY Score: +36.36

Undervalued. Target ~50$.

Recs

0
Member Avatar guinness4life (64.59) Submitted: 12/21/2011 6:21:56 PM : Outperform Start Price: $37.24 LLY Score: +21.78

Long this. Gorgeous value stock with great dividend. I got in a few months ago. Get in the next time a drug misses approval.

Recs

0
Member Avatar Divlover (49.88) Submitted: 12/8/2011 4:09:44 PM : Outperform Start Price: $34.72 LLY Score: +34.58

Possible Alzhiemer drug in the works and a nice dividend.

Recs

0
Member Avatar SearchS (61.34) Submitted: 12/6/2011 9:27:59 PM : Outperform Start Price: $35.01 LLY Score: +35.42

Promising drugs in the pipeline...

Recs

0
Member Avatar birdup (53.23) Submitted: 12/6/2011 7:06:47 PM : Outperform Start Price: $35.01 LLY Score: +35.42

Cramer

Featured Broker Partners


Advertisement